2022 UK cell and gene therapy ecosystem highlights

by Cal Strode | Jan 5, 2023

In 2022, the UK’s Cell and Gene Therapy Catapult (aka CGT Catapult) celebrated its tenth anniversary (congratulations!) marking 10 years of accelerating innovation in cell and gene therapies (CGTs) in the UK. Much like CCRM, CGT Catapult was established as an...

Right Turn: Signals’ Top 10 most popular blogs of 2022

by Stacey Johnson | Dec 30, 2022

Last week bloggers Cal Strode and Tannen Horber shared their favourite blogs from the past year, and I wondered whether there would be any overlap in the Top 10 list below where the number of readers for each post dictates who makes the cut. The answer is “yes.” One...

Right Turn: Favourite blog posts of 2022

by Stacey Johnson | Dec 23, 2022

Having written several “my favourite blog posts” over the years, I decided to turn this very important responsibility over to my communications colleagues at CCRM. I asked Cal Strode and Tannen Horber, who are both contributors and have bios on the site, to pick their...

Right Turn: Lupus’ moment

by Stacey Johnson | Dec 16, 2022

Back in 2014, Selena Gomez was diagnosed with lupus. The singer and actress has been public about getting chemotherapy to treat her condition, and her kidney transplant. The autoimmune disease causes the immune system to attack the body’s tissues and organs....

Having the right country alliances is key for internationalization efforts: South Korea

by CCRM Australia | Dec 6, 2022

Bhavi Kadakia was an intern with CCRM Australia in 2020 and is currently employed at Novotech. In the health-care sector, translation and commercialization have traditionally been described as complex and requiring heavy investment. As such, it is imperative for...

Right Turn: Giving the gift of science

by Stacey Johnson | Dec 2, 2022

The other day someone asked me if I was all ready for Christmas. It wasn’t even December yet! Bah humbug. I don’t have a tree yet, nor am I ready to deal with decorating my house. The only thing I start doing before December is shopping. Not that I’m finished, but I’m...

Right Turn: Experts weigh in on manufacturing of CGTs at JLABS-CCRM event

by Stacey Johnson | Nov 25, 2022

If manufacturing is the gatekeeper to success in the cell and gene therapy space, it’s not surprising that the topic regularly comes up when industry leaders come together to discuss the future or to tackle the challenges we face in commercializing cell and gene...

Takeaway from CDL-CCRM event: Are smart cells the next generation of natural drugs?

by Guest | Nov 17, 2022

Dr. Leili Rohani is a Stem Cell Scientist at the Centre for Heart Lung Innovation (HLI), St. Paul’s Hospital, and a cross-appointed Postdoctoral Fellow at the School of Biomedical Engineering, Department of Medicine, at the University of British Columbia....

Collaborating with Black communities is key to overcoming barriers to stem cell donation – A TMM 2022 talk

by Guest | Nov 10, 2022

Sylvia Okonofua is a donor recruiter with Stem Cell Club. Over the past six years, Sylvia has worked to address racial disparity in access to volunteer, unrelated stem cell donors. She spearheaded “Black Donors Save Lives,” a national campaign she developed in...

Right Turn: Misinformation and mistrust plenary at TMM 2022 – the Australian contribution

by Stacey Johnson | Nov 4, 2022

Despite valiant efforts by countless people and organizations, misinformation and a lack of public trust in science continue to be prevalent themes in 2022. Day two of the Till & McCulloch Meetings in Vancouver kicked off with an informative plenary exploring...